VC-backed Jasper Therapeutics adds new VP to team
Jasper Therapeutics, a biotech company focused on hematopoietic cell transplant therapies, has named Dr. Kevin N. Heller as executive vice president of research and development.
Jasper Therapeutics, a biotech company focused on hematopoietic cell transplant therapies, has named Dr. Kevin N. Heller as executive vice president of research and development.
Copyright PEI Media
Not for publication, email or dissemination